AlzeCure Pharma AB (publ) (FRA:AC6)

Market Cap	21.00M +120.9%
Revenue (ttm)	n/a
Net Income	-3.54M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,000
Open	0.1520
Previous Close	0.1520
Day's Range	0.1520 - 0.1520
52-Week Range	0.0422 - 0.4370
Beta	n/a
RSI	48.87
Earnings Date	Feb 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i...

• Industry: Pharmaceutical Preparations
• Founded: 2012
• Employees: 11
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AC6

Financial Performance

Financial numbers in SEK